Evidence map›Paper›PMID 40321910›Full record

ArticleIranian journal of public health2025

The Role of

Xingxing Wu, Lifang Peng, Mingxu Zheng, Yuqing Mao, Heng Li, Shaopeng Sun

Abstract read
In one paragraph

Article in Iranian journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xingxing WuJiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.
Lifang PengJiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, Shanghai, China.
Mingxu ZhengThe First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Yuqing MaoThe First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Heng LiThe First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
Shaopeng SunThe First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study aimed to investigate the prognostic value of TRP ion channel genes (TRPICGs) in colorectal adenocarcinoma (COAD) and explore its related mechanisms. Methods: The COAD dataset was downloaded from the Cancer Genome Atlas (TCGA) database. The differential expression genes (DEGs) were screened between COAD and normal samples. The differentially expressed TRPICGs (DE-TRPICGs) were obtained via intersection of DEGs and 28 TRPICGs. The Kaplan-Meier (K-M) survival curve was used to screen DE-TRPICGs with survival differences as prognostic markers. Afterward, the correlation of prognostic marker with clinical, immune cell, copy number variation were explored. Finally, immunohistochemistry (IHC) was used to verify the expression of prognostic marker. Results: Overall, 6003 DEGs were screened, and 6 DE-TRPICGs were obtained. Only Conclusion: TRPA1 was identified in COAD as a prognostic marker associated with TRP ion channels, which provided a powerful reference value and a new direction for the diagnosis and treatment of COAD.

Indexed as

Colon adenocarcinomaInfiltrating immune cellsPrognosisTransient receptor potential channel

Identifiers

PMID40321910
PMCPMC12045875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.